Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Genomic diversity of SARS-CoV-2 in Oxford during United Kingdom’s first national lockdown

Journal article

Munis AM. et al, (2021), Scientific Reports, 11

Identification of LZTFL1 as a candidate effector gene at a COVID-19 risk locus.

Journal article

Downes DJ. et al, (2021), Nat Genet, 53, 1606 - 1615

RNA-Seq Analysis of the Human Surfactant Air-Liquid Interface Culture Reveals Alveolar Type II Cell-like Transcriptome

Journal article

Munis AM. et al, (2021), Molecular Therapy - Methods & Clinical Development

A human surfactant B deficiency air-liquid interface cell culture model suitable for gene therapy applications

Journal article

Munis AM. et al, (2021), Molecular Therapy - Methods and Clinical Development, 20, 237 - 246

A tool with many applications: vesicular stomatitis virus in research and medicine.

Journal article

Munis AM. et al, (2020), Expert Opin Biol Ther, 20, 1187 - 1201

Gene Therapy Applications of Non-Human Lentiviral Vectors.

Journal article

Munis AM., (2020), Viruses, 12

Use of Heterologous Vesiculovirus G Proteins Circumvents the Humoral Anti-envelope Immunity in Lentivector-Based In Vivo Gene Delivery

Journal article

Munis AM. et al, (2019), Molecular Therapy - Nucleic Acids, 17, 126 - 137

Lentivector Producer Cell Lines with Stably Expressed Vesiculovirus Envelopes.

Journal article

Tijani M. et al, (2018), Mol Ther Methods Clin Dev, 10, 303 - 312